Andrea Forschner Selected Research

Andrea Forschner Research Topics

Disease

79	Melanoma (Melanoma, Malignant) 03/2024 - 05/2009
36	Neoplasms (Cancer) 06/2024 - 04/2009
16	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2013
9	Skin Neoplasms (Skin Cancer) 01/2023 - 01/2016
7	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2013
5	Disease Progression 10/2023 - 01/2021
5	Hepatitis 01/2022 - 01/2017
4	Uveal melanoma 10/2023 - 05/2019
2	Cytokine Release Syndrome 12/2023 - 01/2023
1	Cardiotoxicity 12/2023
1	cell-associated neurotoxicity 12/2023
1	Fever (Fevers) 01/2023
1	Hypotension (Low Blood Pressure) 01/2023
1	Nervous System Neoplasms (Neoplasms, Nervous System) 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Colitis 01/2022
1	Pancreatitis 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Carcinogenesis 12/2020
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 10/2020
1	Posterior Leukoencephalopathy Syndrome 02/2020
1	Hyperplasia 01/2020
1	Dysplastic Nevus Syndrome (Dysplastic Nevus) 01/2020
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Amelanotic Melanoma (Amelanotic Melanomas) 01/2020
1	Atrophy 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2019

Drug/Important Bio-Agent (IBA)

29	Immune Checkpoint InhibitorsIBA 03/2024 - 09/2015
11	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2024 - 02/2013
9	Biomarkers (Surrogate Marker)IBA 06/2024 - 09/2015
8	NivolumabIBA 01/2023 - 01/2016
8	IpilimumabIBA 01/2023 - 01/2017
6	pembrolizumabIBA 01/2022 - 01/2016
5	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 01/2013
5	AntibodiesIBA 01/2021 - 04/2005
4	Melanins (Melanin)IBA 05/2021 - 12/2016
4	VemurafenibIBA 05/2017 - 02/2013
3	tebentafuspIBA 12/2023 - 01/2023
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2020
3	AntigensIBA 01/2023 - 04/2005
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2022 - 01/2020
3	Circulating Tumor DNAIBA 01/2022 - 12/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2018
3	InterferonsIBA 12/2020 - 11/2016
2	CytokinesIBA 01/2023 - 12/2020
2	binimetinibIBA 01/2021 - 10/2020
2	trametinibIBA 02/2020 - 05/2017
2	serum P-component (CIt)IBA 01/2020 - 01/2020
2	Monoclonal AntibodiesIBA 01/2020 - 01/2017
2	Carboplatin (JM8)FDA LinkGeneric 11/2018 - 05/2009
2	Interferon alpha-2 (Roferon-A)FDA Link 05/2018 - 11/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2017 - 01/2017
2	Immunoglobulins (Immunoglobulin)IBA 12/2017 - 01/2017
2	Antineoplastic Agents (Antineoplastics)IBA 10/2014 - 02/2013
1	SteroidsIBA 03/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2024
1	Infliximab (Remicade)FDA Link 03/2024
1	Bispecific AntibodiesIBA 12/2023
1	SirtuinsIBA 10/2023
1	cyclopropapyrroloindoleIBA 01/2023
1	HLA-A Antigens (HLA-A)IBA 01/2023
1	naporafenibIBA 01/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2023
1	Oncogene Proteins (Oncogene Protein)IBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	Amino Acids FDA Link 10/2021
1	InflammasomesIBA 10/2021
1	vandetanib (ZD6474)IBA 10/2021
1	bosutinibIBA 10/2021
1	TransferasesIBA 04/2021
1	Transaminases (Aminotransferases)IBA 04/2021
1	Calcium-Binding ProteinsIBA 01/2021
1	ribociclibIBA 01/2021
1	TropomyosinIBA 12/2020
1	tyrosine receptor (receptor, tyrosine)IBA 12/2020
1	Indicators and Reagents (Reagents)IBA 12/2020
1	larotrectinibIBA 12/2020
1	Phosphotransferases (Kinase)IBA 12/2020
1	encorafenibIBA 10/2020
1	Tumor Biomarkers (Tumor Markers)IBA 07/2020
1	dabrafenibIBA 02/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	PlacebosIBA 01/2020
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2020
1	pheomelaninIBA 01/2020
1	Cell-Free Nucleic AcidsIBA 12/2019
1	Melphalan (Alkeran)FDA LinkGeneric 05/2019
1	Cisplatin (Platino)FDA LinkGeneric 11/2018
1	Protein Isoforms (Isoforms)IBA 11/2018
1	PlatinumIBA 11/2018

Therapy/Procedure

54	Therapeutics 06/2024 - 04/2009
23	Immunotherapy 12/2023 - 01/2013
7	Radiotherapy 10/2023 - 05/2013
4	Drug Therapy (Chemotherapy) 01/2022 - 05/2009
3	Metastasectomy 07/2020 - 03/2017
3	Aftercare (After-Treatment) 12/2019 - 05/2009
2	Precision Medicine 06/2024 - 01/2023
2	Combination Drug Therapy (Combination Chemotherapy) 01/2013 - 07/2003
1	Withholding Treatment 05/2021